Although it is unlikely that mock demonstrators will be seen at any drug information or regulatory conferences, pharmacovigilance software is indeed having its “Salesforce” moment.
Jim Davis
Advertisement
Articles by Jim Davis
Advertisement
Latest Updated Articles
Pharmacovigilance Software's “Salesforce” MomentPublished: November 12th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Not Planning Increased Proposal Offer After Metsera Enters $10 Billion Amended Merger Agreement with Pfizer
2
Pharma Partnerships Expand as Eli Lilly Announces Strategic Collaborations with MeiraGTx and SanegeneBio
3
Wegovy Demonstrates Reduction in Liver Injury in MASH Patients
4
Pharmaceutical Executive Daily: FDA Approves Darzalex Faspro
5
